ALMS
Price
$29.27
Change
+$2.00 (+7.33%)
Updated
Jul 7, 04:59 PM (EDT)
Capitalization
3.48B
43 days until earnings call
Intraday BUY SELL Signals
SLXN
Price
$2.71
Change
-$0.15 (-5.26%)
Updated
Jul 7, 04:57 PM (EDT)
Capitalization
2.99M
42 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALMS vs SLXN

ALMS vs SLXN Comparison Chart in %
View a ticker or compare two or three
VS
ALMS vs. SLXN commentary
Jul 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALMS is a Buy and SLXN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2026
Stock price -- (ALMS: $26.50 vs. SLXN: $2.64)
Brand notoriety: ALMS and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALMS: 77% vs. SLXN: 3%
Market capitalization -- ALMS: $3.48B vs. SLXN: $2.99M
ALMS [@Biotechnology] is valued at $3.48B. SLXN’s [@Biotechnology] market capitalization is $2.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $134.41B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALMS’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • ALMS’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, ALMS is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALMS’s TA Score shows that 5 TA indicator(s) are bullish while SLXN’s TA Score has 5 bullish TA indicator(s).

  • ALMS’s TA Score: 5 bullish, 5 bearish.
  • SLXN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than ALMS.

Price Growth

ALMS (@Biotechnology) experienced а -2.36% price change this week, while SLXN (@Biotechnology) price change was +2.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.87%. For the same industry, the average monthly price growth was +12.90%, and the average quarterly price growth was +1867.50%.

Reported Earning Dates

ALMS is expected to report earnings on Aug 19, 2026.

SLXN is expected to report earnings on Aug 18, 2026.

Industries' Descriptions

@Biotechnology (+1.87% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALMS($3.48B) has a higher market cap than SLXN($2.99M). ALMS has higher P/E ratio than SLXN: ALMS (0.17) vs SLXN (0.00). ALMS YTD gains are higher at: 171.516 vs. SLXN (-86.224). SLXN has higher annual earnings (EBITDA): -12.91M vs. ALMS (-447.16M). ALMS has more cash in the bank: 523M vs. SLXN (2.41M). SLXN has less debt than ALMS: SLXN (1.99M) vs ALMS (35.7M). ALMS has higher revenues than SLXN: ALMS (8.4M) vs SLXN (0).
ALMSSLXNALMS / SLXN
Capitalization3.48B2.99M116,471%
EBITDA-447.16M-12.91M3,464%
Gain YTD171.516-86.224-199%
P/E Ratio0.170.004,032%
Revenue8.4M0-
Total Cash523M2.41M21,674%
Total Debt35.7M1.99M1,795%
TECHNICAL ANALYSIS
Technical Analysis
ALMSSLXN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
49%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
35%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
42%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 6 days ago
55%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 15 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
62%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ALMS
Daily Signal:
Gain/Loss:
SLXN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDN4.14N/A
N/A
Intellicheck
REG80.96N/A
N/A
Regency Centers Corp
LGHL0.33N/A
N/A
Lion Group Holding Ltd.
EBF21.23-0.26
-1.21%
Ennis
CC18.19-0.82
-4.31%
Chemours Company (The)

ALMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALMS has been loosely correlated with ZNTL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ALMS jumps, then ZNTL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALMS
1D Price
Change %
ALMS100%
N/A
ZNTL - ALMS
34%
Loosely correlated
N/A
ARVN - ALMS
32%
Poorly correlated
N/A
MRNA - ALMS
32%
Poorly correlated
N/A
DRUG - ALMS
32%
Poorly correlated
N/A
VRDN - ALMS
29%
Poorly correlated
N/A
More